JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 6 No. 2 93-108
© 1965 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mabry, C. C.
Right arrow Articles by DeVore, W. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mabry, C. C.
Right arrow Articles by DeVore, W. D.

Measurement of Gastrointestinal Loss of Plasma Albumin: A Clinical and Laboratory Evaluation of 51Chromium Labeled Albumin1,2

C. Charlton Mabry, M.D., Robert H. Greenlaw, M.D. and Waldo D. DeVore, M.S.

Lexington, Kentucky

ABSTRACT

51Chromium albumin, prepared by a standardized method in a commercial radiopharmaceutical laboratory, has been characterized and found to be altered from the parent material and, to a degree, biologically inhomogeneous. It has, however, been shown to be a suitable agent for the clinical evaluation of plasma protein loss into the gastrointestinal tract and to have advantages over other methods and radioisotopes tracers for this purpose. In tracer doses, it does not constitute a radiologic health hazard.

FOOTNOTES

1 From the Departments of Pediatrics and Therapeutic Radiology, University of Kentucky School of Medicine.

2 Supported in part by USPHS Research Grant No. AM-08059 from the National Institute of Health.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1965 by the Society of Nuclear Medicine.